Butt, Adeel Ajwad <br/><br/>
Effect of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ledipasvir/Sofosbuvir Regimens on Survival Compared With Untreated Hepatitis C Virus-Infected Persons: Results From ERCHIVES.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  Sep 2017 
 - 1006-1011 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1093/cid/cix364  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>2-Naphthylamine<br/>Aged<br/>Anilides--therapeutic use<br/>Antiviral Agents--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Carbamates--therapeutic use<br/>Cyclopropanes<br/>Drug Therapy, Combination<br/>Female<br/>Fluorenes--therapeutic use<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lactams, Macrocyclic<br/>Macrocyclic Compounds--therapeutic use<br/>Male<br/>Middle Aged<br/>Proline--analogs & derivatives<br/>Propensity Score<br/>Proportional Hazards Models<br/>Ritonavir--therapeutic use<br/>Sofosbuvir--therapeutic use<br/>Sulfonamides--therapeutic use<br/>Survival Rate<br/>Sustained Virologic Response<br/>Uracil--analogs & derivatives<br/>Valine